Movatterモバイル変換

[0]ホーム
URL:

Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Atypon full text link Atypon Free PMC article
Full text links

Actions

Share

Comparative Study
.2013 Dec 1;31(34):4276-82.
doi: 10.1200/JCO.2013.49.1860. Epub 2013 Oct 28.

Practice patterns and long-term survival for early-stage rectal cancer

Affiliations
Comparative Study

Practice patterns and long-term survival for early-stage rectal cancer

Karyn B Stitzenberg et al. J Clin Oncol..

Abstract

Purpose: Standard of care treatment for most stage I rectal cancers is total mesorectal excision (TME). Given the morbidity associated with TME, local excision (LE) for early-stage rectal cancer has been explored. This study examines practice patterns and overall survival (OS) for early-stage rectal cancer.

Methods: All patients in the National Cancer Data Base diagnosed with rectal cancer from 1998 to 2010 were initially included. Use of LE versus proctectomy and use of adjuvant radiation therapy were compared over time. Adjusted Cox proportional hazards models were used to compare OS based on treatment.

Results: LE was used to treat 46.5% of patients with T1 and 16.8% with T2 tumors. Use of LE increased steadily over time (P < .001). LE was most commonly used for women, black patients, very old patients, those without private health insurance, those with well-differentiated tumors, and those with T1 tumors. Proctectomy was associated with higher rates of tumor-free surgical margins compared with LE (95% v 76%; P < .001). Adjuvant radiation therapy use decreased over time independent of surgical procedure or T stage. For T2N0 disease, patients treated with LE alone had significantly poorer adjusted OS than those treated with proctectomy alone or multimodality therapy.

Conclusion: Guideline-concordant adoption of LE for treatment of low-risk stage I rectal cancer is increasing. However, use of LE is also increasing for higher-risk rectal cancers that do not meet guideline criteria for LE. Treatment with LE alone is associated with poorer long-term OS. Additional studies are warranted to understand the factors driving increased use of LE.

PubMed Disclaimer

Conflict of interest statement

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.

Figures

Fig 1.
Fig 1.
CONSORT diagram. LE, local excision.
Fig 2.
Fig 2.
Changes in use of local excision (LE) to treat rectal cancer over time (patients who received neoadjuvant therapy excluded) by (A) disease stage and (B) subtype of stage I tumors. LE is considered standard-of-care therapy only for select patients with well or moderately differentiated T1N0 rectal cancers.
Fig 3.
Fig 3.
Adjuvant radiation therapy use for stage I rectal cancers by T stage and type of surgical procedure. LE, local excision.
Fig 4.
Fig 4.
Adjusted overall survival by treatment group for T1N0 tumors from (A) 1998 to 2005 (n = 11,528) and (B) 2003 to 2005 (includes comorbidity adjustment; n = 4,295) and for T2N0 tumors from (C) 1998 to 2005 (n = 11,564) and (D) 2003 to 2005 (includes comorbidity adjustment; n = 3,545). HR, hazard ratio.
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet. 1993;341:457–460. - PubMed
    1. Bleier JI, Maykel JA. Outcomes following proctectomy. Surg Clin North Am. 2013;93:89–106. - PubMed
    1. You YN. Local excision: Is it an adequate substitute for radical resection in T1/T2 patients? Semin Radiat Oncol. 2011;21:178–184. - PubMed
    1. Nash GM, Weiser MR, Guillem JG, et al. Long-term survival after transanal excision of T1 rectal cancer. Dis Colon Rectum. 2009;52:577–582. - PubMed
    1. Saraste D, Gunnarsson U, Janson M. Predicting lymph node metastases in early rectal cancer. Eur J Cancer. 2013;49:1104–1108. - PubMed

Publication types

MeSH terms

Related information

Grants and funding

LinkOut - more resources

Full text links
Atypon full text link Atypon Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.

[8]ページ先頭
©2009-2025 Movatter.jp